Response to Fu et al. – (Eye 29, 449 (March 2015))
Response to Fu et al. Eye 29, 449 (March 2015). doi:10.1038/eye.2014.303 Authors: D S Morris, P Desai & C J MacEwen
Two-year outcome of an observe-and-plan regimen for neovascular age-related macular degeneration: how to alleviate the clinical burden with maintained functional results – (Eye 29, 450 (March 2015))
Two-year outcome of an observe-and-plan regimen for neovascular age-related macular degeneration: how to alleviate the clinical burden with maintained functional results Eye 29, 450 (March 2015). doi:10.1038/eye.2014.321 Authors: C Gianniou, A Dirani, W Ferrini, L Marchionno, D Decugis, A Deli, A Ambresin & I Mantel
Choroid thickness and ocular pulse amplitude in migraine during attack – (Eye 29, 452 (March 2015))
Choroid thickness and ocular pulse amplitude in migraine during attack Eye 29, 452 (March 2015). doi:10.1038/eye.2015.4 Authors: M S Dervisogullari, Y Totan & O S Gençler
Neuropathic ocular pain: an important yet underevaluated feature of dry eye – (Eye 29, 301 (March 2015))
Neuropathic ocular pain: an important yet underevaluated feature of dry eye Eye 29, 301 (March 2015). doi:10.1038/eye.2014.263 Authors: A Galor, R C Levitt, E R Felix, E R Martin & C D Sarantopoulos
Randomised clinical trial evaluating best-corrected visual acuity and central macular thickness after 532-nm subthreshold laser grid photocoagulation treatment in diabetic macular oedema – (Eye 29, 313 (March 2015))
Randomised clinical trial evaluating best-corrected visual acuity and central macular thickness after 532-nm subthreshold laser grid photocoagulation treatment in diabetic macular oedema Eye 29, 313 (March 2015). doi:10.1038/eye.2015.1 Authors: W Pei-pei, H Shi-zhou, T Zhen, L Lin, L Ying, O Jiexiong, Z Wen-bo & J Chen-jin